Lakefront Biotherapeutics NV

Amsterdam: LKFT

+0.02 (0.08%)↑ EOD

EOD price at Jun 5, 5:30:01 PM CEST • Market Closed

Is it expensive?

Market Cap

Explainer

Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

0.00

Trailing P/E Ratio

Explainer

Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

3.16

Forward P/E Ratio

Explainer

Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

-6.56

PEG Ratio

Explainer

PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

-6.56

Enterprise Value

-1.43B

Enterprise Value to EBITDA

-2.16

Price-to-Sales (TTM)

Explainer

Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

0.00

Price-to-Book (MRQ)

0.49

Book Value per Share (MRQ)

49.39

Is it profitable?

Revenue (TTM)

1.04B

Net Profit Margin (TTM)

Explainer

Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

What Is Profit Margin? Formula, Sector Ranges, and Traps

46.83%

Gross Profit Margin

Explainer

Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

What Is Profit Margin? Formula, Sector Ranges, and Traps

25.95%

Diluted EPS (TTM)

Explainer

Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

Earnings per Share (EPS): The Key Metric That Beats Headline Profits

7.41

Return on Equity (TTM)

16.26%

Is it growing?

Revenue Growth (MRQ)

-91.40%

Earnings Growth (YOY)

0.00%

Is it risky?

Beta

0.12

Debt to Equity (MRQ)

0.20

Total Debt (MRQ)

6.44M

Current Ratio (MRQ)

30.48

Who owns it?

Institutional Ownership

32.42%

Insider Ownership

25.36%

Short Interest

0.00%

Shares Outstanding

65.90M

Shares Float

44.54M

Does it pay?

Forward Dividend Yield

0.00%

Payout Ratio

0.00%

Ex. Dividend Date

Dividend Date

How much cash?

Total Cash (MRQ)

2.98B

Operating Cash Flow (TTM)

-301.60M

Levered Free Cash Flow (TTM)

210.97M

Total Cash per Share (MRQ)

45.26

Indicators

Biotechnology

Operating Cash Flow

-301.60M

÷0

Net Income

487.93M

Warning Sign

-0.62

Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Indicators

Biotechnology

Operating Cash Flow

-301.60M

÷0

Net Income

487.93M

Warning Sign

-0.62

Reported profit and cash flow are moving in opposite directions. This is a major red flag associated with aggressive accounting, financial stress, or early-stage distress.

Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.

Is it expensive?

Market Cap

Explainer

Market Cap calculates a company's market value. It answers: "How big is this company and what size risk am I taking?"

0.00

Trailing P/E Ratio

Explainer

Trailing P/E shows what you are paying for each dollar of last year's earnings. It answers: "How expensive is this stock relative to its past year's profits?"

3.16

Forward P/E Ratio

Explainer

Forward P/E shows what you are paying for each dollar of next year's projected earnings. It answers: "How expensive is this stock relative to its expected future profits?"

-6.56

PEG Ratio

Explainer

PEG Ratio measures if a stock is expensive relative to its growth rate. It answers: "Am I paying a fair price for growth?"

-6.56

Enterprise Value

-1.43B

Enterprise Value to EBITDA

-2.16

Price-to-Sales (TTM)

Explainer

Price-to-Sales (TTM) shows what you pay for each dollar of the company's revenue. It answers: "How expensive is this stock relative to sales?"

0.00

Price-to-Book (MRQ)

0.49

Book Value per Share (MRQ)

49.39

Is it profitable?

Revenue (TTM)

1.04B

Net Profit Margin (TTM)

Explainer

Net Profit Margin (TTM) shows what percentage of revenue remains after all costs. It answers: "How much does the company keep as a final profit?"

What Is Profit Margin? Formula, Sector Ranges, and Traps

46.83%

Gross Profit Margin

Explainer

Gross Profit Margin shows what percentage of revenue remains after direct costs. It answers: "How much does the company keep before operating costs?"

What Is Profit Margin? Formula, Sector Ranges, and Traps

25.95%

Diluted EPS (TTM)

Explainer

Diluted EPS (TTM) shows the profit per share over the last 12 months. It answers: "How profitable is each share I buy?"

Earnings per Share (EPS): The Key Metric That Beats Headline Profits

7.41

Return on Equity (TTM)

16.26%

Is it growing?

Revenue Growth (MRQ)

-91.40%

Earnings Growth (YOY)

0.00%

Is it risky?

Beta

0.12

Debt to Equity (MRQ)

0.20

Total Debt (MRQ)

6.44M

Current Ratio (MRQ)

30.48

Who owns it?

Institutional Ownership

32.42%

Insider Ownership

25.36%

Short Interest

0.00%

Shares Outstanding

65.90M

Shares Float

44.54M

Does it pay?

Forward Dividend Yield

0.00%

Payout Ratio

0.00%

Ex. Dividend Date

Dividend Date

How much cash?

Total Cash (MRQ)

2.98B

Operating Cash Flow (TTM)

-301.60M

Levered Free Cash Flow (TTM)

210.97M

Total Cash per Share (MRQ)

45.26

Lakefront Biotherapeutics NV

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Indicators

Indicators

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Lakefront Biotherapeutics NV

Stock Details

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers

Indicators

Indicators

Stock Details

Is it expensive?

Is it profitable?

Is it growing?

Is it risky?

Who owns it?

Does it pay?

How much cash?

52-Week Range Position (52WRP)

Multi-Timeframe Analysis (MTA)

Rate of Change (ROC)

Relative Volume (RVOL)

Exchange Identifiers